bird-flu-stocks-logo
birdflustocks.com
Moderna: mRNA-1010 Seasonal Influenza Vaccine phase 3 study successfully completed
birdflustocks.com » bird flu stocks  »  Moderna: mRNA-1010 Seasonal Influenza Vaccine phase 3 study successfully completed
Moderna: mRNA-1010 Seasonal Influenza Vaccine phase 3 study successfully completed
September 13, 2023

https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-scale-down-manufacturing-covid-vaccine-2023-09-13/